Fabricator: Dragon Pharma, Europe
Unit: x1 10 ml
Strength: 400 mg/ml
If your order hasn’t arrived within 35 days after shipping, we’ll resend it for free.
Dragon Pharma Testabol 400 delivers 400 mg of combined testosterone esters per milliliter in a highly concentrated oil solution. This advanced fusion unites Acetate, Enanthate, and Decanoate into a single powerful injection designed for maximum hormonal impact with minimal oil volume.
The sophisticated multi-ester matrix provides immediate anabolic surge, sustained mid-duration release, and extended baseline coverage. This eliminates the peaks and troughs common to single-ester protocols while reducing total injection frequency.
This triple-ester suspension combines three distinct testosterone variants with complementary pharmacokinetic profiles. Acetate delivers rapid onset within hours, Enanthate builds steady plasma levels over days, and Decanoate ensures prolonged hormonal coverage for weeks.
The result is a seamless anabolic continuum. Users experience immediate strength and fullness from the Acetate fraction while the longer esters accumulate to create powerful, stable blood concentrations.
The 400 mg/mL concentration significantly reduces injection volume. An 800 mg weekly requirement demands only 2 mL of oil, cutting administration frequency and localized tissue trauma compared to standard 250 mg/mL formulations.
Dragon Pharma employs advanced solvent systems and sterile manufacturing to maintain suspension stability at this high concentration. This technical achievement prevents crystallization and minimizes post-injection discomfort.
Each milliliter contains 400 mg of total testosterone in a blended ester matrix. The composition includes Testosterone Acetate, Testosterone Enanthate, and Testosterone Decanoate.
The formulation utilizes pharmaceutical-grade carrier oils, benzyl alcohol as an antimicrobial preservative, and advanced co-solvents to ensure stable suspension and optimal pharmacokinetics.
All raw materials undergo independent verification for identity, potency, and sterility prior to compounding.
Administer via deep intramuscular injection into large muscle groups. Rotate between the gluteal muscles, ventrogluteal site, vastus lateralis, and deltoids to prevent localized tissue fibrosis.
Warm the vial gently to body temperature before drawing to reduce viscosity. Aspirate prior to plunging to confirm extravascular placement.
Maintain strict aseptic technique. Cleanse the rubber septum with isopropyl alcohol before each access. Utilize sterile needles for every administration and never share injection equipment.
Store unopened vials in a temperature-stable environment between 15–30°C (59–86°F), shielded from direct light. Do not freeze.
Advanced users typically administer 400–800 mg weekly. Split this into two injections, for example 1 mL twice weekly, to account for the Acetate ester and maintain stable blood levels.
Elite performance protocols may reach 800–1200 mg weekly. At these doses, divide into three administrations every other day to manage estrogenic side effects and post-injection discomfort.
The 400 mg/mL concentration can increase injection site soreness. Warming the oil, injecting slowly, using a 1–1.5 inch needle, and meticulous site rotation minimize this effect.
The high testosterone load drives substantial aromatization. Water retention, elevated blood pressure, and gynecomastia can appear quickly and severely without proactive estrogen management.
Aggressive aromatase inhibitor use is mandatory from day one. The Acetate fraction causes early estrogenic activity, requiring immediate ancillary support rather than delayed intervention.
Androgenic manifestations including acne, increased sebum production, and accelerated scalp hair thinning in genetically predisposed individuals are common at higher doses.
Exogenous testosterone completely suppresses hypothalamic-pituitary-gonadal axis function. A robust Post-Cycle Therapy protocol using Clomiphene and Tamoxifen is absolutely critical.
Wait approximately 3 weeks after the final injection before initiating PCT. This allows the long Decanoate ester to clear systemic circulation completely.
Lipid profiles may deteriorate significantly, with HDL suppression and LDL elevation. Regular cardiovascular exercise and a heart-healthy diet are essential protective measures.
This product is intended exclusively for research purposes and use by qualified adults under appropriate supervision. It is not suitable for minors, women, or individuals with pre-existing hepatic, cardiovascular, or prostate conditions.
Regular blood work monitoring total testosterone, estradiol, liver enzymes, and lipids is essential throughout the cycle. Adjust ancillary dosing based on objective laboratory values.
Maintain a heart-healthy diet rich in omega-3 fatty acids and low in saturated fats. Regular cardiovascular exercise supports vascular health and lipid management.
Discontinue immediately and seek medical evaluation if severe chest pain, shortness of breath, jaundice, or profound mood disturbances develop.
Please log in to write Testabol 400 review.
Testabol 400 utilizes Acetate, Enanthate, and Decanoate at a higher 400 mg/mL concentration. Testo Blend 350 combines Propionate, Enanthate, and Cypionate at 350 mg/mL.
The Acetate in Testabol 400 provides faster onset than Propionate, while Decanoate offers longer duration than Cypionate.
Twice weekly is the minimum effective frequency due to the Acetate component. Three times weekly provides even greater stability at higher doses and reduces post-injection discomfort.
The Decanoate ester has an extended elimination half-life. Starting PCT too early is ineffective because exogenous testosterone remains in circulation and continues suppressing the axis.
This high-concentration multi-ester formulation is designed for advanced users who understand injection technique, estrogen management, and extended PCT requirements.
Dragon Pharma employs advanced solvent systems to maintain suspension stability at 400 mg/mL. However, high-concentration blends are inherently more susceptible to crashing if exposed to cold temperatures. Warm the vial gently if any crystallization occurs.